4
Changes in Ownership
Actinium Pharmaceuticals, Inc. Filed Acc 0001213900-25-028225
Options or other derivatives
- Chief Financial Officer returned 706,588 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
O'Loughlin Steve · Chief Financial Officer
Table II: Derivative
9 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-03-31 | Returned to the company : show line 1 in the form Stock Option (Right to Buy) | −3,333 | 0 | D |
| 2025-03-31 | Returned to the company : show line 2 in the form Stock Option (Right to Buy) | −1,666 | 0 | D |
| 2025-03-31 | Returned to the company : show line 3 in the form Stock Option (Right to Buy) | −3,333 | 0 | D |
| 2025-03-31 | Returned to the company : show line 4 in the form Stock Option (Right to Buy) | −8,833 | 0 | D |
| 2025-03-31 | Returned to the company : show line 5 in the form Stock Option (Right to Buy) | −13,333 | 0 | D |
| 2025-03-31 | Returned to the company : show line 6 in the form Stock Option (Right to Buy) | −59,066 | 0 | D |
| 2025-03-31 | Returned to the company : show line 7 in the form Stock Option (Right to Buy) | −107,463 | 0 | D |
| 2025-03-31 | Returned to the company : show line 8 in the form Stock Option (Right to Buy) | −256,438 | 0 | D |
| 2025-03-31 | Returned to the company : show line 9 in the form Stock Option (Right to Buy) | −253,123 | 0 | D |
Loading xslF345X05/ownership.xml…